← All indications
Myofibroma
A benign tumor that consists chiefly of fibrous CONNECTIVE TISSUE, with variable numbers of MUSCLE CELLS forming portions of the neoplasm (From Stedman's, 27th ed).
Organizations
Organization Involved with Phase 4 Indications (23)
- National Institutes of Health (NIH)
- Triệu, Nguyễn Thị, M.D.
- Mansoura University
- NHS Lothian
- Northwestern University
- University of Edinburgh
- University of Milan
- University of Toronto
- Mayo Clinic
- Peking University
- Tel Aviv University
- University of California, Los Angeles
- University of California, San Francisco
- University of Chicago
- Icahn School of Medicine at Mount Sinai
- Tran Minh Duc, Dr.
- Orebro University
- The University of Hong Kong
- Magna Graecia University
- University of Sao Paulo
- Chinese Academy of Medical Sciences
- China Resources Zizhu Pharmaceutical Co., Ltd.
- My Duc Phu Nhuan Hospital
Organization Involved with Phase 3 Indications (22)
- Abbott
- AbbVie
- Takeda
- Forest Laboratories
- Allergan
- Bayer
- Myovant Sciences GmbH
- ObsEva SA
- Ain Shams University
- Cairo University
- Eastern Virginia Medical School
- Mediterranea Medica S. L.
- Ilsan Hospital
- Royan Institute
- Seoul National University
- University of Miami
- University of Valencia
- Cha Medical University
- Watson Pharmaceuticals
- Repros Therapeutics
- Gedeon Richter Ltd.
- Northern Ontario School of Medicine
Organization Involved with Phase 2 Indications (9)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (7)